Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.
Yong-Kui YuFan-Yu MengXiu-Feng WeiXian-Kai ChenHao-Miao LiQi LiuCan-Jun LiHou-Nai XieLei XuRui-Xiang ZhangWenqun XingYin LiPublished in: The Journal of thoracic and cardiovascular surgery (2024)
NACI has R0 resection and pCR rates comparable to those of NCRT and seems to be correlated with better prognosis than NCRT. NACI followed by surgery may be an effective treatment strategy for locally advanced ESCC.